COSCIENS Biopharma Inc. (LON:0UGB)

London · Delayed Price · Currency is GBP · Price in CAD

4.200

-0.050 (-1.18%)

At close: Jan 22, 2025

COSCIENS Biopharma Employees

COSCIENS Biopharma had 40 employees as of December 31, 2024. The number of employees increased by 28 or 233.33% compared to the previous year.

Employees

40

Change

28

Growth

233.33%

Revenue / Employee

172.29K GBP

Profits / Employee

-343.82K GBP

Market Cap

6.10M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	40	28	233.33%
Dec 31, 2020	12	-44	-78.57%
Dec 31, 2014	56	-	-

Related Stocks

Company Name	Employees
HSBC Holdings	211,304
Unilever	115,964
BP p.l.c.	100,500
Shell	96,000
AstraZeneca	94,300
GSK plc	68,629
Rio Tinto Group	60,000
British American Tobacco p.l.c.	48,989

Employee Rankings

COSCIENS Biopharma News

2 months ago - COSCIENS Biopharma Inc. Reports Second Quarter 2025 Financial Results and Provides Strategic Initiatives Update - GlobeNewsWire
4 months ago - COSCIENS Biopharma Announces Results of Virtual 2025 Meeting of Shareholders - GlobeNewsWire
5 months ago - COSCIENS Biopharma Inc. Acknowledges Receipt of Intended Director Nominations from Goodwood for the Upcoming Annual and Special Meeting of Shareholders - GlobeNewsWire
6 months ago - COSCIENS Biopharma Inc. Reports First Quarter 2025 Financial Results and Provides a Corporate Update - GlobeNewsWire
7 months ago - COSCIENS Biopharma Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Corporate Update - GlobeNewsWire
7 months ago - COSCIENS Biopharma Inc. Announces Receipt of Management Cease Trade Order - GlobeNewsWire
8 months ago - COSCIENS Biopharma Inc. Announces Possible Delay in Filing Year-End Reporting Documents - Newsfile Corp
8 months ago - COSCIENS Biopharma Inc. Announces Successful Phase 1 Results Supporting Initiation of Phase 2a Clinical Efficacy Trial with Avenanthramides as a Potential Anti-Inflammatory Product - GlobeNewsWire